| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
Department of Pediatrics, Division of Nephrology, School of Medicine, University of California, Davis, California.
Correspondence to Dr. Sudesh Paul Makker, 1515 Newton Court, Neuroscience Building, Room 603, Department of Pediatrics, University of California, Davis, CA 95616. Phone: 530-754-5161; Fax: 530-757-8945; E-mail: spmakker{at}ucdavis.edu
Abstract. Active Heymann nephritis of rat, an autoimmune glomerular disease, is an immunohistological, ultrastructural, and clinical model of human membranous glomerulonephritis. Both diseases in their full-blown form are characterized by (1) the formation of large, subepithelial glomerular immune deposits, which stain for IgG, C3, and membrane attack (C5b-9) components of complement and (2) the excretion of large amounts of protein in the urine (proteinuria). The target autoantigen of active Heymann nephritis is a large transmembrane renal glycoprotein with a molecular weight of approximately 600 kD, variously named gp600, gp330, LRP-2, or "megalin." This study was performed to identify the region in this enormously large glycoprotein that would produce full-blown active Heymann nephritis. A stable, small (60-kD) proteolytic fragment of gp600 was isolated and localized to the N-terminal end of the molecule using Western blot, sequencing, and amino acid analyses. Based on its primary structure, this fragment contains approximately 60 cysteine residues, the cross-linking of which to each other probably explains its stability. Immunization of rats with this fragment induced a full-blown disease that was comparable to the disease induced by a preparation containing the whole protein. These results indicate that this small fragment, retaining the natural disulfide bonds and probably its overall structure, contains those B and T cell epitopes that are sufficient to produce this organ-specific autoimmune disease.
This article has been cited by other articles:
![]() |
P. Shah, A. Tramontano, and S. P. Makker Intramolecular Epitope Spreading in Heymann Nephritis J. Am. Soc. Nephrol., December 1, 2007; 18(12): 3060 - 3066. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tramontano, T. Knight, D. Vizzuso, and S. P. Makker Nested N-Terminal Megalin Fragments Induce High-Titer Autoantibody and Attenuated Heymann Nephritis J. Am. Soc. Nephrol., July 1, 2006; 17(7): 1979 - 1985. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ronco and H. Debiec Molecular Dissection of Target Antigens and Nephritogenic Antibodies in Membranous Nephropathy: Towards Epitope-Driven Therapies J. Am. Soc. Nephrol., July 1, 2006; 17(7): 1772 - 1774. [Full Text] [PDF] |
||||
![]() |
M. Nangaku, S. J. Shankland, and W. G. Couser Cellular Response to Injury in Membranous Nephropathy J. Am. Soc. Nephrol., May 1, 2005; 16(5): 1195 - 1204. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tramontano and S. P. Makker Conformation and Glycosylation of a Megalin Fragment Correlate with Nephritogenicity in Heymann Nephritis J. Immunol., February 15, 2004; 172(4): 2367 - 2373. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Pavenstadt, W. Kriz, and M. Kretzler Cell Biology of the Glomerular Podocyte Physiol Rev, January 1, 2003; 83(1): 253 - 307. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Zhao, J. Letterman, and B. M. Schreiber beta -Migrating Very Low Density Lipoprotein (beta VLDL) Activates Smooth Muscle Cell Mitogen-activated Protein (MAP) Kinase via G Protein-coupled Receptor-mediated Transactivation of the Epidermal Growth Factor (EGF) Receptor. EFFECT OF MAP KINASE ACTIVATION ON beta VLDL PLUS EGF-INDUCED CELL PROLIFERATION J. Biol. Chem., August 10, 2001; 276(33): 30579 - 30588. [Abstract] [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673